PFM Health Sciences’s Orexigen Therapeutics, Inc. OREX Stock Holding History

PFM Health Sciences’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-527,867	Closed	-$26.1M	–	114
2015 Q2	$26.1M	Buy	527,867 +240,818	+84%	+$14.4M	0.66%	48
2015 Q1	$22.5M	Sell	287,049 -30,927	-10%	-$1.92M	0.62%	56
2014 Q4	$19.3M	Sell	317,976 -165,856	-34%	-$8.33M	0.45%	59
2014 Q3	$20.6M	Buy	483,832 +23,336	+5%	+$1.25M	0.47%	45
2014 Q2	$28.5M	Sell	460,496 -52,417	-10%	-$3.05M	0.57%	43
2014 Q1	$33.3M	Buy	512,913 +8,201	+2%	+$555K	0.6%	46
2013 Q4	$28.4M	Buy	504,712 +146,378	+41%	+$8.23M	0.57%	41
2013 Q3	$22M	Sell	358,334 -6,292	-2%	-$426K	0.53%	43
2013 Q2	$21.3M	Buy	+364,626	New	+$22.4M	0.44%	48

Other funds holding OREX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PFM Health Sciences's OREX Position: Q3 2015 in Review

PFM Health Sciences sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2015, closing a stake of 527,867 shares — an estimated $26.1M sold.

PFM Health Sciences first reported a position in OREX in Q2 2013 and held it in 9 quarters. The position peaked at $33.3M in Q1 2014. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

PFM Health Sciences reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
PFM Health Sciences sold 527,867 Orexigen Therapeutics, Inc. shares in Q3 2015, an estimated $26.1M.
PFM Health Sciences first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 9 quarters.
PFM Health Sciences's Orexigen Therapeutics, Inc. position peaked at $33.3M in Q1 2014.
132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.